. Author manuscript; available in PMC: 2014 Apr 16.

Published in final edited form as: Auton Neurosci. 2013 Aug 20;177(2):291–296. doi: 10.1016/j.autneu.2013.08.064

Table 2.

Risk of non-persistence on treatments for orthostatic hypotension

Risk of Discontinuation or Change in Treatmet
Treatment	Number of episodes of use	Number of events	Median duration on treatment (IQR)	Unadjusted Hazard Ratio (95% confidence interval)	Adjusted Hazard Ratio (95% confidence interval)
Fludrocortisone	1103	329	254 (119–783)	Reference	Reference
Midodrine	664	210	259 (119–807)	1.04 (0.89, 1.24)	1.07 (0.90, 1.28)
Risk of Discontinuation
Fludrocortisone	1103	298	268 (119, 816)	Reference	Reference
Midodrine	664	169	304 (133, 865)	0.93 (0.77, 1.11)	0.97 (0.80, 1.18)